All Stories

  1. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand

    Article • Pharmacological Reviews, September 2019, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  2. International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function

    Article • Pharmacological Reviews, December 2017, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  3. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors

    Article • British Journal of Pharmacology, October 2017, Wiley

    Dr Christopher Southan, Dr Anthony P Davenport, Stephen Alexander, Professor Jamie A Davies

  4. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

    Article • British Journal of Pharmacology, October 2017, Wiley

    Dr Christopher Southan, Dr Anthony P Davenport, Professor Israel Hanukoglu, Professor Jamie A Davies, Prof daniel hoyer, Professor of Vascular Physiology Lucie Clapp

  5. Pharmacological targeting of apelin impairs glioblastoma growth

    Article • Brain, October 2017, Oxford University Press (OUP)

    Dr Anthony P Davenport

  6. Detection of Atherosclerotic Inflammation by 68 Ga-DOTATATE PET Compared to [ 18 F]FDG PET Imaging

    Article • Journal of the American College of Cardiology, April 2017, Elsevier

    Dr Anthony P Davenport

  7. Vascular Imaging With 18 F-Fluorodeoxyglucose Positron Emission Tomography Is Influenced by Hypoxia

    Article • Journal of the American College of Cardiology, April 2017, Elsevier

    Dr Anthony P Davenport

  8. 18 F-Fluoride and 18 F-Fluorodeoxyglucose Positron Emission Tomography After Transient Ischemic Attack or Minor Ischemic StrokeCLINICAL PERSPECTIVE

    Article • Circulation Cardiovascular Imaging, March 2017, Wolters Kluwer Health

    Dr Anthony P Davenport

  9. [Pyr1]Apelin-13(1–12) Is a Biologically Active ACE2 Metabolite of the Endogenous Cardiovascular Peptide [Pyr1]Apelin-13

    Article • Frontiers in Neuroscience, February 2017, Frontiers

    Dr Anthony P Davenport

  10. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial HypertensionClinical Perspective

    Article • Circulation, January 2017, Wolters Kluwer Health

    Dr Anthony P Davenport

  11. OUP accepted manuscript

    Article • Nucleic Acids Research, January 2017, Oxford University Press (OUP)

    Dr Christopher Southan, Dr Anthony P Davenport, Stephen Alexander

  12. Smooth Muscle Endothelin B Receptors Regulate Blood Pressure but Not Vascular Function or Neointimal RemodelingNovelty and Significance

    Article • Hypertension, December 2016, Wolters Kluwer Health

    Dr Anthony P Davenport

  13. Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature

    Article • Journal of the American Heart Association, October 2016, Wolters Kluwer Health

    Dr Anthony P Davenport

  14. Cardiac action of the first G protein biased small molecule apelin agonist

    Article • Biochemical Pharmacology, September 2016, Elsevier

    Dr Anthony P Davenport

  15. Endothelin ETA receptors predominate in chronic thromboembolic pulmonary hypertension

    Article • Life Sciences, August 2016, Elsevier

    Dr Anthony P Davenport

  16. The endothelin hormones, structure and function

    Article • Pharmacological Reviews, March 2016, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Christopher Southan, Dr Anthony P Davenport

  17. The Prodomain-bound Form of Bone Morphogenetic Protein 10 Is Biologically Active on Endothelial Cells

    Article • Journal of Biological Chemistry, December 2015, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Anthony P Davenport

  18. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors

    Article • British Journal of Pharmacology, December 2015, Wiley

    Dr Christopher Southan, Dr Anthony P Davenport, Dr Kenneth A. Jacobson, Stephen Alexander

  19. The Concise Guide to PHARMACOLOGY 2015/16: Overview

    Article • British Journal of Pharmacology, December 2015, Wiley

    Dr Anthony P Davenport, Stephen Alexander, Prof daniel hoyer

  20. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands

    Article • Nucleic Acids Research, October 2015, Oxford University Press (OUP)

    Dr Christopher Southan, Dr Anthony P Davenport, Stephen Alexander

  21. Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system

    Article • Trends in Pharmacological Sciences, September 2015, Elsevier

    Dr Anthony P Davenport

  22. Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography

    Article • Nature Communications, July 2015, Nature

    Dr Anthony P Davenport

  23. LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2015, Endocrine Society

    Dr Anthony P Davenport

  24. Endothelin Receptors and Their Antagonists

    Article • Seminars in Nephrology, March 2015, Elsevier

    Dr Anthony P Davenport

  25. Design, Characterization, and First-In-Human Study of the Vascular Actions of a Novel Biased Apelin Receptor Agonist

    Article • Hypertension, February 2015, Wolters Kluwer Health

    Dr Anthony P Davenport

  26. Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12

    Article • British Journal of Pharmacology, November 2014, Wiley

    Dr Anthony P Davenport

  27. Changes in biomechanical properties of the coronary artery wall contribute to maintained contractile responses to endothelin-1 in atherosclerosis

    Article • Life Sciences, November 2014, Elsevier

    Dr Anthony P Davenport

  28. Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension

    Article • Life Sciences, November 2014, Elsevier

    Dr Anthony P Davenport

  29. In Vivo Mapping of Vascular Inflammation Using the Translocator Protein Tracer 18 F-FEDAA1106

    Article • Molecular Imaging, August 2014, Decker, Inc.

    Dr Anthony P Davenport, dr Willy Gsell

  30. Characterization of [125I]GLP-1(9-36), a novel radiolabeled analog of the major metabolite of glucagon-like peptide 1 to a receptor distinct from GLP1-R and function of the peptide in murine aorta

    Article • Life Sciences, May 2014, Elsevier

    Dr Anthony P Davenport

  31. The CCR5 chemokine receptor mediates vasoconstriction and stimulates intimal hyperplasia in human vessels in vitro

    Article • Cardiovascular Research, December 2013, European Society of Cardiology

    Dr Anthony P Davenport

  32. The Concise Guide to PHARMACOLOGY 2013/14: Overview

    Article • British Journal of Pharmacology, December 2013, Wiley

    Dr Anthony P Davenport, Stephen Alexander, Prof daniel hoyer

  33. The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

    Article • Nucleic Acids Research, November 2013, Oxford University Press (OUP)

    Dr Christopher Southan, Dr Anthony P Davenport, Stephen Alexander

  34. Evolving pharmacology of orphan GPCRs: IUPHAR Commentary

    Article • British Journal of Pharmacology, October 2013, Wiley

    Dr Anthony P Davenport

  35. No evidence for a local renin-angiotensin system in liver mitochondria

    Article • Scientific Reports, August 2013, Nature

    Dr Anthony P Davenport, Hugh Montgomery, Professor Po Sing Leung

  36. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension

    Article • Nature Genetics, August 2013, Nature

    Dr Anthony P Davenport

  37. Screening β-Arrestin Recruitment for the Identification of Natural Ligands for Orphan G-Protein–Coupled Receptors

    Article • SLAS DISCOVERY, June 2013, SAGE Publications

    Dr Anthony P Davenport

  38. International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands

    Article • Pharmacological Reviews, May 2013, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport, Stephen Alexander

  39. Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer

    Article • British Journal of Pharmacology, December 2012, Wiley

    Dr Anthony P Davenport

  40. Themed section: endothelin

    Article • British Journal of Pharmacology, December 2012, Wiley

    Dr Anthony P Davenport

  41. IUPHAR-DB: updated database content and new features

    Article • Nucleic Acids Research, October 2012, Oxford University Press (OUP)

    Dr Anthony P Davenport

  42. The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans

    Article • Life Sciences, October 2012, Elsevier

    Professor john j mcmurray, Dr Anthony P Davenport

  43. Comparison of endothelin receptors in normal versus cirrhotic human liver and in the liver from endothelial cell-specific ETB knockout mice

    Article • Life Sciences, October 2012, Elsevier

    Dr Anthony P Davenport

  44. Comparison of human ETA and ETB receptor signalling via G-protein and β-arrestin pathways

    Article • Life Sciences, October 2012, Elsevier

    Dr Anthony P Davenport

  45. Defining the affinity and receptor sub-type selectivity of four classes of endothelin antagonists in clinically relevant human cardiovascular tissues

    Article • Life Sciences, October 2012, Elsevier

    Dr Anthony P Davenport

  46. The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011

    Article • Life Sciences, October 2012, Elsevier

    Dr Anthony P Davenport

  47. GuideToPharmacology.org - an update

    Article • British Journal of Pharmacology, September 2012, Wiley

    Professor Alistair Mathie, Stephen Alexander, Dr Anthony P Davenport

  48. Cellular Localization of Receptors Using Antibodies Visualized by Light and Dual Labeling Confocal Microscopy

    Article • January 2012, Springer Science + Business Media

    Dr Anthony P Davenport

  49. Dynamic In Vivo Imaging of Receptors in Small Animals Using Positron Emission Tomography

    Article • January 2012, Springer Science + Business Media

    Dr Anthony P Davenport

  50. How to Use the IUPHAR Receptor Database to Navigate Pharmacological Data

    Article • January 2012, Springer Science + Business Media

    Dr Anthony P Davenport

  51. Quantitative Phosphor Imaging Autoradiography of Radioligands for Positron Emission Tomography

    Article • January 2012, Springer Science + Business Media

    Dr Anthony P Davenport

  52. Radioligand Binding Assays and Their Analysis

    Article • January 2012, Springer Science + Business Media

    Dr Anthony P Davenport

  53. Receptor Binding Techniques

    Article • January 2012, Springer Science + Business Media

    Dr Anthony P Davenport

  54. Inotropic Action of the Puberty Hormone Kisspeptin in Rat, Mouse and Human: Cardiovascular Distribution and Characteristics of the Kisspeptin Receptor

    Article • PLoS ONE, November 2011, PLOS

    Dr Anthony P Davenport

  55. Importance of Subtype Selectivity for Endothelin Receptor Antagonists in the Human Vasculature

    Article • October 2011, Springer Science + Business Media

    Dr Anthony P Davenport

  56. Discovery of a Competitive Apelin Receptor (APJ) Antagonist

    Article • ChemMedChem, May 2011, Wiley

    Dr Anthony P Davenport

  57. Chemokine receptor CCR5: from AIDS to atherosclerosis

    Article • British Journal of Pharmacology, March 2011, Wiley

    Dr Anthony P Davenport

  58. Pharmacology of Renal Endothelin Receptors

    Article • January 2011, Karger Publishers

    Dr Anthony P Davenport

  59. International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin Receptor Nomenclature, Distribution, and Function

    Article • Pharmacological Reviews, November 2010, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  60. Evidence for a novel vasospastic transmitter system, neuromedin U, in the equine digital circulation

    Article • The Veterinary Journal, October 2010, Elsevier

    Dr Anthony P Davenport

  61. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin Receptor Nomenclature, Distribution, Pharmacology, and Function

    Article • Pharmacological Reviews, July 2010, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  62. Endothelial cell-specific ETBreceptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1This article is one of a selection of papers published in the two-part special issue entitled 20 Years o...

    Article • Canadian Journal of Physiology and Pharmacology, June 2010, Canadian Science Publishing

    Dr Anthony P Davenport

  63. Evaluation of translocator protein quantification as a tool for characterising macrophage burden in human carotid atherosclerosis

    Article • Atherosclerosis, June 2010, Elsevier

    Dr Anthony P Davenport

  64. Introduction

    Article • Canadian Journal of Physiology and Pharmacology, June 2010, Canadian Science Publishing

    Dr Anthony P Davenport

  65. Modulation of the apelin/APJ system in heart failure and atherosclerosis in man

    Article • British Journal of Pharmacology, April 2010, Wiley

    Dr Anthony P Davenport

  66. Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver

    Article • British Journal of Pharmacology, February 2010, Wiley

    Dr Anthony P Davenport

  67. EDITORIAL

    Article • British Journal of Pharmacology, February 2010, Wiley

    Dr Anthony P Davenport

  68. The endothelin system in pulmonary and renal vasculopathy: les liaisons dangereuses

    Article • European Respiratory Review, November 2009, European Respiratory Society (ERS)

    Dr Anthony P Davenport

  69. FDG–PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis

    Article • The International Journal of Cardiovascular Imaging, September 2009, Springer Science + Business Media

    Dr Anthony P Davenport

  70. Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

    Article • British Journal of Pharmacology, September 2009, Wiley

    Dr Anthony P Davenport

  71. [Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart: Vasoactive Mechanisms and Inotropic Action in Disease

    Article • Hypertension, July 2009, Wolters Kluwer Health

    Dr Anthony P Davenport

  72. International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature

    Article • Pharmacological Reviews, March 2009, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  73. Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation

    Article • British Journal of Pharmacology, January 2009, Wiley

    Dr Anthony P Davenport

  74. Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system

    Article • British Journal of Pharmacology, January 2009, Wiley

    Dr Anthony P Davenport

  75. Positron emission tomography using 18F-labelled endothelin-1 reveals prevention of binding to cardiac receptors owing to tissue-specific clearance by ETB receptors in vivo

    Article • British Journal of Pharmacology, January 2009, Wiley

    Dr Anthony P Davenport

  76. Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system

    Article • Cardiovascular Research, December 2008, European Society of Cardiology

    Dr Anthony P Davenport

  77. IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels

    Article • Nucleic Acids Research, October 2008, Oxford University Press (OUP)

    Dr Anthony P Davenport

  78. Automated synthesis of the generic peptide labelling agent N-succinimidyl 4-[18F]fluorobenzoate and application to 18F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography

    Article • Nuclear Medicine and Biology, August 2008, Elsevier

    Dr Anthony P Davenport

  79. Chronic Apoptosis of Vascular Smooth Muscle Cells Accelerates Atherosclerosis and Promotes Calcification and Medial Degeneration

    Article • Circulation Research, May 2008, Wolters Kluwer Health

    Dr Anthony P Davenport

  80. Immunocytochemical localization of the urotensin-II receptor, UT, to rat and human tissues: Relevance to function

    Article • Peptides, May 2008, Elsevier

    Dr Anthony P Davenport

  81. Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease

    Article • Nephrology Dialysis Transplantation, June 2007, Oxford University Press (OUP)

    Dr Anthony P Davenport

  82. Strategy for improved [11C]DAA1106 radiosynthesis and in vivo peripheral benzodiazepine receptor imaging using microPET, evaluation of [11C]DAA1106

    Article • Nuclear Medicine and Biology, May 2007, Elsevier

    Dr Anthony P Davenport

  83. Kisspeptins Are Novel Potent Vasoconstrictors in Humans, with a Discrete Localization of Their Receptor, G Protein-Coupled Receptor 54, to Atherosclerosis-Prone Vessels

    Article • Endocrinology, January 2007, Endocrine Society

    Dr Anthony P Davenport

  84. Endothelin Receptors

    Article • January 2007, Elsevier

    Dr Anthony P Davenport

  85. Urotensin-II Receptor

    Article • January 2007, Elsevier

    Dr Anthony P Davenport

  86. ET-B Endothelin Receptor

    Article • January 2007, Elsevier

    Dr Anthony P Davenport

  87. ET-A Endothelin Receptor

    Article • January 2007, Elsevier

    Dr Anthony P Davenport

  88. Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation

    Article • British Journal of Pharmacology, December 2006, Wiley

    Dr Anthony P Davenport

  89. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis

    Article • Nature Medicine, August 2006, Nature

    Dr Anthony P Davenport

  90. Neuropeptide B and W: neurotransmitters in an emerging G-protein-coupled receptor system

    Article • British Journal of Pharmacology, August 2006, Wiley

    Dr Anthony P Davenport

  91. Novel Snake Venom Ligand Dendroaspis Natriuretic Peptide Is Selective for Natriuretic Peptide Receptor-A in Human Heart: Downregulation of Natriuretic Peptide Receptor-A in Heart Failure

    Article • Circulation Research, July 2006, Wolters Kluwer Health

    Dr Anthony P Davenport

  92. Deletion of Endothelial Cell Endothelin B Receptors Does Not Affect Blood Pressure or Sensitivity to Salt

    Article • Hypertension, June 2006, Wolters Kluwer Health

    Dr Anthony P Davenport

  93. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man

    Article • Cardiovascular Research, January 2006, European Society of Cardiology

    Dr Anthony P Davenport

  94. International Union of Pharmacology. LVI. Ghrelin Receptor Nomenclature, Distribution, and Function

    Article • Pharmacological Reviews, December 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  95. Triptan-induced contractile (5-HT1Breceptor) responses in human cerebral and coronary arteries: relationship to clinical effect

    Article • Clinical Science, September 2005, Portland Press Ltd.

    Dr Anthony P Davenport

  96. Emerging roles of apelin in biology and medicine

    Article • Pharmacology & Therapeutics, August 2005, Elsevier

    Dr Anthony P Davenport

  97. Regulation of vascular reactivity by established and emerging GPCRs

    Article • Trends in Pharmacological Sciences, July 2005, Elsevier

    Dr Anthony P Davenport

  98. International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List

    Article • Pharmacological Reviews, May 2005, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  99. Receptor Binding Techniques

    Article • March 2005, Springer Science + Business Media

    Dr Anthony P Davenport

  100. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells

    Article • Regulatory Peptides, March 2005, Elsevier

    Dr Anthony P Davenport

  101. Alternative Pathway to Endothelin-Converting Enzyme for the Synthesis of Endothelin in Human Blood Vessels

    Article • Journal of Cardiovascular Pharmacology, November 2004, Wolters Kluwer Health

    Dr Anthony P Davenport

  102. Comparison of Endothelin-A and Endothelin-B Receptor Distribution Visualized by Radioligand Binding versus Immunocytochemical Localization using Subtype Selective Antisera

    Article • Journal of Cardiovascular Pharmacology, November 2004, Wolters Kluwer Health

    Dr Anthony P Davenport

  103. Down-regulation of ETA Receptors in ETB Receptor-deficient Mice

    Article • Journal of Cardiovascular Pharmacology, November 2004, Wolters Kluwer Health

    Dr Anthony P Davenport

  104. Endothelin Receptor Pharmacology and Function in the Mouse: Comparison with Rat and Man

    Article • Journal of Cardiovascular Pharmacology, November 2004, Wolters Kluwer Health

    Dr Anthony P Davenport

  105. In Vivo Imaging of Cardiovascular Endothelin Receptors Using the Novel Radiolabelled Antagonist [18F]-SB209670 and Positron Emission Tomography (microPET)

    Article • Journal of Cardiovascular Pharmacology, November 2004, Wolters Kluwer Health

    Dr Anthony P Davenport

  106. CRF2receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators

    Article • British Journal of Pharmacology, October 2004, Wiley

    Dr Anthony P Davenport

  107. Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries

    Article • Peptides, October 2004, Elsevier

    Dr Anthony P Davenport

  108. Regional Hemodynamic Actions of Selective Corticotropin-Releasing Factor Type 2 Receptor Ligands in Conscious Rats

    Article • Journal of Pharmacology and Experimental Therapeutics, August 2004, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  109. Identification and cellular localisation of NPW1 (GPR7) receptors for the novel neuropeptide W-23 by [125I]-NPW radioligand binding and immunocytochemistry

    Article • Brain Research, August 2004, Elsevier

    Dr Anthony P Davenport

  110. Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells

    Article • Regulatory Peptides, May 2004, Elsevier

    Dr Anthony P Davenport

  111. Maternal Dexamethasone Increases Endothelin-1 Sensitivity and Endothelin A Receptor Expression in Ovine Foetal Placental Arteries

    Article • Placenta, April 2003, Elsevier

    Dr Anthony P Davenport

  112. Peptide and trace amine orphan receptors: prospects for new therapeutic targets

    Article • Current Opinion in Pharmacology, April 2003, Elsevier

    Dr Anthony P Davenport

  113. Translating the human genome: renaissance of cardiovascular receptor pharmacology

    Article • Current Opinion in Pharmacology, April 2003, Elsevier

    Dr Anthony P Davenport

  114. Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system

    Article • Trends in Pharmacological Sciences, January 2003, Elsevier

    Dr Anthony P Davenport

  115. Life before birth: effects of cortisol on future cardiovascular and metabolic function*

    Article • Acta Paediatrica, January 2003, Wiley

    Dr Anthony P Davenport

  116. Is urotensin-II the new endothelin?

    Article • British Journal of Pharmacology, November 2002, Wiley

    Dr Anthony P Davenport

  117. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1

    Article • British Journal of Pharmacology, August 2002, Wiley

    Dr Anthony P Davenport

  118. Peptide Research Protocols

    Article • June 2002, Springer Science + Business Media

    Dr Anthony P Davenport

  119. International Union of Pharmacology. XXIX. Update on Endothelin Receptor Nomenclature

    Article • Pharmacological Reviews, June 2002, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Anthony P Davenport

  120. Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography

    Article • Circulation, May 2002, Wolters Kluwer Health

    Dr Anthony P Davenport

  121. Discovery of recently adopted orphan receptors for apelin, urotensin II, and ghrelin identified using novel radioligands and functional role in the human cardiovascular system

    Article • Canadian Journal of Physiology and Pharmacology, May 2002, Canadian Science Publishing

    Dr Anthony P Davenport

  122. Of mice and men: advances in endothelin research and first antagonist gains FDA approval

    Article • Trends in Pharmacological Sciences, April 2002, Elsevier

    Dr Anthony P Davenport

  123. Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors

    Article • British Journal of Clinical Pharmacology, January 2002, Wiley

    Dr Anthony P Davenport

  124. Radioligand binding reveals chymase as the predominant enzyme for mediating tissue conversion of angiotensin I in the normal human heart

    Article • Clinical Science, January 2002, Portland Press Ltd.

    Dr Anthony P Davenport

  125. Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT1receptor antagonist losartan

    Article • British Journal of Pharmacology, December 2001, Wiley

    Dr Anthony P Davenport

  126. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteriesin vitro

    Article • British Journal of Pharmacology, November 2001, Wiley

    Dr Anthony P Davenport

  127. [125I-His9]-Ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue; up-regulation of receptors with atherosclerosis

    Article • British Journal of Pharmacology, September 2001, Wiley

    Dr Anthony P Davenport

  128. Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery

    Article • British Journal of Pharmacology, June 2001, Wiley

    Dr Anthony P Davenport

  129. Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats

    Article • British Journal of Pharmacology, April 2001, Wiley

    Dr Anthony P Davenport

  130. The endothelin system in human saphenous vein graft disease

    Article • Current Opinion in Pharmacology, April 2001, Elsevier

    Dr Anthony P Davenport

  131. [125I]-(Pyr1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man

    Article • British Journal of Pharmacology, March 2001, Wiley

    Dr Anthony P Davenport

  132. Nitric oxide-mediated modulation of the endothelin-1 signalling pathway in the human cardiovascular system

    Article • British Journal of Pharmacology, January 2001, Wiley

    Dr Anthony P Davenport

  133. Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1

    Article • British Journal of Pharmacology, October 2000, Wiley

    Dr Anthony P Davenport

  134. Endothelin receptor antagonism in patients with chronic heart failure

    Article • Cardiovascular Research, July 2000, European Society of Cardiology

    Professor john j mcmurray, Dr Anthony P Davenport

  135. Urotensin II: fish neuropeptide catches orphan receptor

    Article • Trends in Pharmacological Sciences, March 2000, Elsevier

    Dr Anthony P Davenport

  136. Preface

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Jose Krieger, Dr Anthony P Davenport

  137. Cellular Expression of Isoforms of Endothelin-Converting Enzyme-1 (ECE-1c, ECE-1b and ECE-1a) and Endothelin-Converting Enzyme-2

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  138. Changes in ETA-, AT1- and AT2-Receptors in the Phenotypically Transformed Intimal Smooth Muscle Layer of Human Atherosclerotic Coronary Arteries

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  139. Endothelin-A-Receptors in Human Aorta and Pulmonary Arteries are Downregulated in Patients With Cardiovascular Disease

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  140. Expression and Characterization of the Human Endothelin-A-Receptor in Pichia pastoris

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  141. No Alteration in Vasoconstrictor Endothelin-B-Receptor Density or Function in Human Coronary Artery Disease

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  142. Novel Nitric Oxide Donors Reverse Endothelin-1-Mediated Constriction in Human Blood Vessels

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  143. Syntheses of the First Endothelin-A- and -B-Selective Radioligands for Positron Emission Tomography

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  144. Tissue-Specific Modulation of Endothelin Receptors in a Rat Model of Hypertension

    Article • Journal of Cardiovascular Pharmacology, January 2000, Wolters Kluwer Health

    Dr Anthony P Davenport

  145. Evidence for Intracellular Endothelin-Converting Enzyme-2 Expression in Cultured Human Vascular Endothelial Cells

    Article • Circulation Research, April 1999, Wolters Kluwer Health

    Dr Anthony P Davenport

  146. Blockade and Reversal of Endothelin-Induced Constriction in Pial Arteries From Human Brain   Editorial Comment

    Article • Stroke, March 1999, Wolters Kluwer Health

    Dr Anthony P Davenport

  147. Endothelin receptor expression and pharmacology in human saphenous vein graft

    Article • British Journal of Pharmacology, January 1999, Wiley

    Dr Anthony P Davenport

  148. Secretory pathways in endothelin synthesis

    Article • British Journal of Pharmacology, January 1999, Wiley

    Dr Anthony P Davenport

  149. The therapeutic potential of PD156707 and related butenolide endothelin antagonists

    Article • Expert Opinion on Investigational Drugs, January 1999, Informa Healthcare

    Dr Anthony P Davenport

  150. The haemodynamic effects of iodinated water soluble radiographic contrast media: a review

    Article • European Journal of Radiology, November 1998, Elsevier

    Dr Anthony P Davenport

  151. Expression of EndothelinA Receptors in Human Gliomas and Meningiomas, with High Affinity for the Selective Antagonist PD156707

    Article • Neurosurgery, October 1998, Oxford University Press (OUP)

    Dr Anthony P Davenport

  152. Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease

    Article • British Journal of Pharmacology, September 1998, Wiley

    Dr Anthony P Davenport

  153. Human Endothelial Cell Storage Granules : A Novel Intracellular Site for Isoforms of the Endothelin-Converting Enzyme

    Article • Circulation Research, August 1998, Wolters Kluwer Health

    Dr Anthony P Davenport

  154. Endothelin receptor subtypes and their functional relevance in human small coronary arteries

    Article • British Journal of Pharmacology, June 1998, Wiley

    Dr Anthony P Davenport

  155. Evidence Using Immunoelectron Microscopy for Regulated and Constitutive Pathways in the Transport and Release of Endothelin

    Article • Journal of Cardiovascular Pharmacology, March 1998, Wolters Kluwer Health

    Dr Anthony P Davenport

  156. In vitro enzymatic processing of radiolabelled big ET-1 in human kidney

    Article • Biochemical Pharmacology, March 1998, Elsevier

    Dr Anthony P Davenport

  157. Characterization of [125I]-PD164333, an ETAselective non-peptide radiolabelled antagonist, in normal and diseased human tissues

    Article • British Journal of Pharmacology, January 1998, Wiley

    Dr Anthony P Davenport

  158. Characterization of Site-Directed Antisera Against Endothelin-Converting Enzymes

    Article • Journal of Cardiovascular Pharmacology, January 1998, Wolters Kluwer Health

    Dr Anthony P Davenport

  159. Endothelin Peptide and Converting Enzymes in Human Endothelium

    Article • Journal of Cardiovascular Pharmacology, January 1998, Wolters Kluwer Health

    Dr Anthony P Davenport

  160. Endothelin-Converting Enzyme in the Human Vasculature: Evidence for Differential Conversion of Big Endothelin-3 by Endothelial and Smooth-Muscle Cells

    Article • Journal of Cardiovascular Pharmacology, January 1998, Wolters Kluwer Health

    Dr Anthony P Davenport

  161. PD156707: A Potent Antagonist of Endothelin-1 in Human Diseased Coronary Arteries and Vein Grafts

    Article • Journal of Cardiovascular Pharmacology, January 1998, Wolters Kluwer Health

    Dr Anthony P Davenport

  162. Relative Contribution of Endothelin A and Endothelin B Receptors to Vasoconstriction in Small Arteries from Human Heart and Brain

    Article • Journal of Cardiovascular Pharmacology, January 1998, Wolters Kluwer Health

    Dr Anthony P Davenport

  163. Article • The Histochemical Journal, January 1998, Springer Science + Business Media

    Dr Anthony P Davenport

  164. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle

    Article • British Journal of Pharmacology, December 1997, Wiley

    Dr Anthony P Davenport

  165. Detection of Endothelin Receptors in Human Coronary Artery Vascular Smooth Muscle Cells But Not Endothelial Cells by Using Electron Microscope Autoradiography

    Article • Journal of Cardiovascular Pharmacology, June 1997, Wolters Kluwer Health

    Dr Anthony P Davenport

  166. Differential distribution of endothelin receptor subtypes in placentae from normal and growth-restricted pregnancies

    Article • Placenta, March 1997, Elsevier

    Dr Anthony P Davenport

  167. Differential distribution of endothelin peptides and receptors in human adrenal gland

    Article • The Histochemical Journal, November 1996, Springer Science + Business Media

    Dr Anthony P Davenport

  168. Characterization of the binding of endothelin ETB selective ligands in human and rat heart

    Article • British Journal of Pharmacology, October 1996, Wiley

    Dr Anthony P Davenport

  169. Endothelin Peptide and Receptors in Human Atherosclerotic Coronary Artery and Aorta

    Article • Circulation Research, October 1996, Wolters Kluwer Health

    Dr Anthony P Davenport

  170. Selective downregulation of ETA receptor mRNA in renal transplant recipients on cyclosporin A revealed by quantitative RT-PCR

    Article • Nephrology Dialysis Transplantation, October 1996, Oxford University Press (OUP)

    Dr Anthony P Davenport

  171. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044

    Article • British Journal of Pharmacology, September 1996, Wiley

    Dr Anthony P Davenport

  172. Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments

    Article • British Journal of Pharmacology, May 1996, Wiley

    Dr Anthony P Davenport

  173. The endothelin system in the kidney

    Article • Nephrology, April 1996, Wiley

    Dr Anthony P Davenport

  174. Endothelin receptors in human coronary artery and aorta

    Article • British Journal of Pharmacology, March 1996, Wiley

    Dr Anthony P Davenport

  175. Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart

    Article • British Journal of Pharmacology, February 1996, Wiley

    Dr Anthony P Davenport

  176. Localization of endothelin peptides in human kidney

    Article • Kidney International, February 1996, Elsevier

    Dr Anthony P Davenport

  177. Endocrinology and paracrinology

    Article • Molecular Human Reproduction, January 1996, Oxford University Press (OUP)

    Dr Anthony P Davenport

  178. Radioligand Binding Assays: Theory and Practice

    Article • January 1996, Springer Science + Business Media

    Dr Anthony P Davenport

  179. Expression of Endothelin Peptides and Mrna in the Human Heart

    Article • Clinical Science, January 1996, Portland Press Ltd.

    Dr Anthony P Davenport

  180. Endothelin ETA receptor expression in human cerebrovascular smooth muscle cells

    Article • British Journal of Pharmacology, November 1995, Wiley

    Dr Anthony P Davenport

  181. Phosphoramidon inhibition of the in vivo conversion of big endothelin-1 to endothelin-1 in the human forearm

    Article • British Journal of Pharmacology, September 1995, Wiley

    Dr Anthony P Davenport

  182. Endothelin expression in the uterus

    Article • The Journal of Steroid Biochemistry and Molecular Biology, June 1995, Elsevier

    Dr Anthony P Davenport

  183. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro

    Article • British Journal of Pharmacology, May 1995, Wiley

    Dr Anthony P Davenport

  184. Endothelin ETA and ETB mRNA and receptors expressed by smooth muscle in the human vasculature: majority of the ETA sub-type

    Article • British Journal of Pharmacology, March 1995, Wiley

    Dr Anthony P Davenport

  185. ETA and ETB endothelin receptors in human myometrium characterized by the subtype selective ligands BQ123, BQ3020, FR139317 and PD151242

    Article • Journal of Endocrinology, January 1995, Bioscientifica

    Dr Anthony P Davenport

  186. Secretion of endothelin-1 and endothelin-3 by human cultured vascular smooth muscle cells

    Article • British Journal of Pharmacology, January 1995, Wiley

    Dr Anthony P Davenport

  187. Selectivity of [125I]-PD 151242 for human, rat and porcine endothelin ETA receptors in the heart

    Article • British Journal of Pharmacology, January 1995, Wiley

    Dr Anthony P Davenport

  188. [125I]-PD151242: a selective ligand for endothelin ETA receptors in human kidney which localizes to renal vasculature

    Article • British Journal of Pharmacology, December 1994, Wiley

    Dr Anthony P Davenport

  189. Vasoconstrictor endothelin receptors characterized in human renal artery and vein in vitro

    Article • British Journal of Pharmacology, September 1994, Wiley

    Dr Anthony P Davenport

  190. Quantification of mRNA in Human Tissue Using Fluorescent Nested Reverse-Transcriptase Polymerase Chain Reaction

    Article • Analytical Biochemistry, August 1994, Elsevier

    Dr Anthony P Davenport

  191. Effects of Phosphoramidon and Pepstatin a on the Secretion of Endothelin-I and Big Endothelin-I by Human Umbilical Vein Endothelial Cells: Measurement by Two-Site Enzyme-Linked Immunosorbent Assays

    Article • Clinical Science, August 1994, Portland Press Ltd.

    Dr Anthony P Davenport

  192. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats

    Article • British Journal of Pharmacology, June 1994, Wiley

    Dr Anthony P Davenport

  193. Davenport and Maguire reply

    Article • Trends in Pharmacological Sciences, May 1994, Elsevier

    Dr Anthony P Davenport

  194. Validation of mRNA Quantification in Human Kidney by a Novel Fluorescent Nested RT-PCR Method

    Article • Clinical Science, January 1994, Portland Press Ltd.

    Dr Anthony P Davenport

  195. Is endothelin-induced vasoconstriction mediated only by ETA receptors in humans?

    Article • Trends in Pharmacological Sciences, January 1994, Elsevier

    Dr Anthony P Davenport

  196. [125I]-PD 151242: a selective radioligand for human ETA receptors

    Article • British Journal of Pharmacology, January 1994, Wiley

    Dr Anthony P Davenport

  197. Isolation of Human Cardiac Endothelin Receptors by a Peptide-Receptor Mobility Shift Assay

    Article • Clinical Science, August 1993, Portland Press Ltd.

    Dr Anthony P Davenport

  198. Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney

    Article • Kidney International, July 1993, Elsevier

    Dr Anthony P Davenport

  199. Alternatively Spliced mRNAs for Human Endothelin-2 and Their Tissue Distribution

    Article • Biochemical and Biophysical Research Communications, June 1993, Elsevier

    Dr Anthony P Davenport

  200. Endothelin: progress in pharmacology and physiology

    Article • Trends in Pharmacological Sciences, June 1993, Elsevier

    Dr Anthony P Davenport

  201. Identification of endothelin-1, endothelin-2 and endothelin-3 in human endometrium

    Article • Reproduction, May 1993, Bioscientifica

    Dr Anthony P Davenport

  202. Characterisation of Immunoreactive Endothelin in Human kidney by RP-HPLC and RIA

    Article • Clinical Science, March 1993, Portland Press Ltd.

    Dr Anthony P Davenport

  203. Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium

    Article • Circulation Research, March 1993, Wolters Kluwer Health

    Dr Anthony P Davenport

  204. Quantitative autoradiography reveals higher densities of specific calcitonin-gene-related peptide receptors in small intramyocardial compared with large epicardial coronary arteries

    Article • Clinical Science, January 1993, Portland Press Ltd.

    Dr Anthony P Davenport

  205. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle.

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1992, Endocrine Society

    Professor Stephen Charnock-Jones, Dr Anthony P Davenport

  206. Presence of messenger ribonucleic acid for endothelin-1, endothelin-2, and endothelin-3 in human endometrium and a change in the ratio of ETA and ETB receptor subtype across the menstrual cycle

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1992, Endocrine Society

    Dr Anthony P Davenport

  207. Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart

    Article • British Journal of Pharmacology, November 1992, Wiley

    Dr Anthony P Davenport

  208. Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue

    Article • Journal of Hypertension, November 1992, Wolters Kluwer Health

    Dr Anthony P Davenport

  209. Localization of immunoreactive endothelin and proendothelin in the human lung

    Article • Pulmonary Pharmacology, September 1992, Elsevier

    Dr Anthony P Davenport

  210. Endothelin-like immunoreactivity in human endometrium

    Article • Reproduction, July 1992, Bioscientifica

    Dr Anthony P Davenport

  211. Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b

    Article • Brain Research, May 1992, Elsevier

    Dr Anthony P Davenport

  212. Endothelins in reproduction

    Article • Reproductive Medicine Review, March 1992, Cambridge University Press

    Dr Anthony P Davenport

  213. Localization and endogenous concentration of endothelin-like immunoreactivity in human placenta

    Article • Journal of Endocrinology, December 1991, Bioscientifica

    Dr Anthony P Davenport

  214. Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues

    Article • Human Reproduction, October 1991, Oxford University Press (OUP)

    Dr Anthony P Davenport

  215. Binding sites for125I ET-1, ET-2, ET-3 and vasoactive intestinal contractor are present in adult rat brain and neurone-enriched primary cultures of embryonic brain cells

    Article • Brain Research, July 1991, Elsevier

    Dr Anthony P Davenport

  216. Binding sites for iodinated endothelin-1, endothelin-2 and endothelin-3 demonstrated on human uterine glandular epithelial cells by quantitative high-resolution autoradiography

    Article • Journal of Endocrinology, April 1991, Bioscientifica

    Dr Anthony P Davenport

  217. Mitogenic Effects of Vasoactive Peptides on Rat Vascular Smooth Muscle Cells

    Article • Clinical Science, March 1991, Portland Press Ltd.

    Dr Anthony P Davenport

  218. Endothelin-1 stimulates prostaglandin F2α release from human endometrium

    Article • Prostaglandins Leukotrienes and Essential Fatty Acids, March 1991, Elsevier

    Dr Anthony P Davenport

  219. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells

    Article • Atherosclerosis, December 1990, Elsevier

    Dr Anthony P Davenport

  220. Atrial natriuretic factor mRNA and binding sites in the adrenal gland

    Article • Biochemical Journal, October 1990, Portland Press Ltd.

    Dr Anthony P Davenport

  221. Localisation off binding sites for iodinated endothelin and saraffotoxin peptides in mammalian tissues using quantitative receptor autoradiography

    Article • European Journal of Pharmacology, July 1990, Elsevier

    Dr Anthony P Davenport

  222. Endothelin-1 mRNA is widely expressed in porcine and human tissues.

    Article • Journal of Clinical Investigation, May 1990, American Society for Clinical Investigation

    Dr Anthony P Davenport

  223. A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects

    Article • Clinical Science, March 1990, Portland Press Ltd.

    Dr Anthony P Davenport

  224. Binding Sites for125I-Labelled Endothelin-1 in the Kidneys: Differential Distribution in Rat, Pig and Man Demonstrated by Using Quantitative Autoradiography

    Article • Clinical Science, August 1989, Portland Press Ltd.

    Dr Anthony P Davenport

  225. Experimental hemiparkinsonism in the rat following chronic unilateral infusion of MPP+ into the nigrostriatal dopamine pathway—II. Differential localization of dopamine and cholecystokinin receptors

    Article • Neuroscience, October 1988, Elsevier

    Dr Anthony P Davenport

  226. Comparison between brain paste and polymer [125I]standards for quantitative receptor autoradiography

    Article • Journal of Neuroscience Methods, August 1988, Elsevier

    Dr Anthony P Davenport

  227. Effect of the formamidine insecticide chordimeform on feeding and reproduction in the noctuid moth, Spodoptera littoralis (Boisduval)

    Article • Crop Protection, February 1987, Elsevier

    Dr Anthony P Davenport

  228. Quantitative receptor autoradiography

    Article • Nature, December 1986, Nature

    Dr Anthony P Davenport

  229. Sex-related differences in the concentration of Met-enkephalin-like immunoreactivity in the nervous system of an insect,Schistocerca gregaria, revealed by radioimmunoassay

    Article • Brain Research, September 1986, Elsevier

    Dr Anthony P Davenport

  230. Octopamine distribution in the larvae and adults of two species of moth, Spodoptera littoralis and Manduca sexta

    Article • Journal of Insect Physiology, January 1986, Elsevier

    Dr Anthony P Davenport

  231. The action of formamidines on octopamine receptors in the locust

    Article • Pesticide Biochemistry and Physiology, August 1985, Elsevier

    Dr Anthony P Davenport

  232. Toxicity of chlordimeform and amitraz to the egyptian cotton leafworm (Spodoptera littoralis) and the tobacco budworm (Heliothis virescens)

    Article • Pesticide Science, February 1985, Wiley

    Dr Anthony P Davenport

  233. Changes in haemolymph octopamine levels associated with food deprivation in the locust, Schistocerca gregaria

    Article • Physiological Entomology, September 1984, Wiley

    Dr Anthony P Davenport

  234. Stress-induced changes in the octopamine levels of insect haemolymph

    Article • Insect Biochemistry, January 1984, Elsevier

    Dr Anthony P Davenport

  235. Biogenic amines in the brain of the honeybee, Apis mellifera

    Article • Cell and Tissue Research, December 1983, Springer Science + Business Media

    Dr Anthony P Davenport

  236. Dynamic In Vivo Imaging of Receptors in Small Animals Using Positron Emission Tomography

    Article • Springer Science + Business Media

    Dr Anthony P Davenport

  237. Imaging and Characterization of Radioligands for Positron Emission Tomography Using Quantitative Phosphor Imaging Autoradiography

    Article • Springer Science + Business Media

    Dr Anthony P Davenport

  238. Immunocytochemical Localization of Receptors Using Light and Confocal Microscopy With Application to the Phenotypic Characterization of Knock-Out Mice

    Article • Springer Science + Business Media

    Dr Anthony P Davenport

  239. Radioligand-Binding and Molecular-Imaging Techniques for the Quantitative Analysis of Established and Emerging Orphan Receptor Systems

    Article • Springer Science + Business Media

    Dr Anthony P Davenport

  240. Apelins and the Apelin Receptor

    Article • Springer Science + Business Media

    Dr Anthony P Davenport

  241. Radioligand Binding Assays and Quantitative Autoradiography of Endothelin Receptors

    Article • Springer Science + Business Media

    Dr Anthony P Davenport

  242. Analysis of Endothelins by Enzyme-Linked Immunosorbent Assay and Radioimmunoassay

    Article • Springer Science + Business Media

    Dr Anthony P Davenport